Bringing Your Innovations to European Patients

News & Events

Here you will find an overview of selected current and completed projects and undertakings of the IGES Group and its subsidiaries.

BIO-Europe Spring 2024

BIO-Europe Spring 2024

IGES at the BIO-Europe Spring 2024

Current Status EU-HTA

Current Status EU-HTA

Current documents on the EU-HTA process and opportunity to provide feedback

EU-HTA: 12th January 2025

EU-HTA: 12th January 2025

Pharmaceuticals: The countdown to EU-HTA runs

IGES at ISPOR 2023 in Copenhagen

IGES at ISPOR 2023 in Copenhagen

HTA, Market Access and Strategy in Europe, EU-HTA Stakeholder

BIO EUROPE 2023

BIO EUROPE 2023

EU HTA harmonisation under time pressure: discussion at the biotech congress "BIO Europe 2023"

IGES France Pharma Consulting

IGES France Pharma Consulting

IGES sets up a new subsidiary in France – IGES France Pharma Consulting

Synergus RWE

Synergus RWE

IGES acquires majority stake in Synergus RWE – a European Medtech market access specialist